Disclosures for "Effects of the Strong CYP3A4 and P-glycoprotein Inhibitor Itraconazole on the Pharmacokinetics of Oral and Intranasal Zavegepant")
-
The institution of Dr. Bhardwaj has received personal compensation in the range of $0-$499 for serving as a Consultant for Certara.
-
Ms. Malatesta has nothing to disclose.
-
Joseph Stringfellow has nothing to disclose.
-
Jennifer Madonia has received personal compensation for serving as an employee of Biohaven Pharmaceuticals. Jennifer Madonia has stock in Biohaven Pharmaceuticals.
-
Matt Anderson has received personal compensation for serving as an employee of Certara. An immediate family member of Matt Anderson has received personal compensation for serving as an employee of Bristol Myers Squibb. Matt Anderson has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Certara Strategic Consulting. An immediate family member of Matt Anderson has received stock or an ownership interest from Bristol Myers Squibb.
-
Beth Morris has received personal compensation for serving as an employee of Biohaven Pharmaceuticals Inc. Beth Morris has received stock or an ownership interest from Biohaven Pharmaceuticals Inc.
-
Vlad Coric has received personal compensation for serving as an employee of Biohaven. Vlad Coric has received stock or an ownership interest from Biohaven. Vlad Coric has received intellectual property interests from a discovery or technology relating to health care.
-
Dr. Croop has received personal compensation for serving as an employee of Biohaven Pharmaceuticals, Inc. Dr. Croop has stock in Biohaven Pharmaceutical Holding Co Ltd. Dr. Croop has received intellectual property interests from a discovery or technology relating to health care.
-
Richard Bertz has received personal compensation for serving as an employee of Biohaven Pharmaceuticals. Richard Bertz has stock in Biohaven Pharmaceuticals.